混合IgE-IgG1抗体 (IgEG):一种新的抗体类别,它结合了IgE和IgG功能
Melanie Grandits1,2, Lais C G F Palhares1,2, Olivia Macleod2
1St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London, UK.
mAbs
|May 16, 2025
概括
工程混合IgE-IgG1抗体 (IgEGs) 结合了两种免疫球蛋白类型的功能. 这些新型癌症疗法在治疗固体瘤方面显示出提高疗效和安全性的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 基于免疫球蛋白G (IgG) 的疗法在癌症治疗中表现有前途,但反应率有变化,特别是在固体瘤中.
- 免疫球蛋白E (IgE) 抗体引起独特的免疫反应,并在临床前和早期临床研究中显示出抗瘤潜力.
- 需要更强大,更有效的基于抗体的癌症疗法.
研究的目的:
- 设计一种新的混合抗体,将IgE和IgG1 (IgEG) 的功能性质结合起来,以增强抗癌功效.
- 评估工程IgEGs的体外和体内特征,包括功能,稳定性,安全性和抗瘤功效.
主要方法:
- 使用trastuzumab和一种新型抗HER2IgE的可变区域生成两种混合IgE-IgG1抗体 (IgEG).
- 评估IgEG表达,稳定性,体外IgE和IgG1功能以及I型过敏的可能性.
- 在相关模型中评估体内药理动力学概况和抗瘤疗效.
主要成果:
- 工程IgEGs在哺乳动物细胞中成功表达,并表现出IgE类稳定性.
- 在人体血液检测中,IgEGs在体外显示出IgE和IgG1的双重功能,没有I型过敏的迹象.
- 在体内研究显示出明显的药物动力学特征和与IgE相比的抗瘤疗效.
结论:
- 新的IgE-IgG1混合抗体 (IgEG) 有效地结合了两种免疫球蛋白同型的功能属性.
- IgEGs表现出有希望的抗瘤疗效和可能有利的安全性,这表明过敏性降低了.
- IgEG代表了瘤学,特别是固体瘤的潜在新疗法.
更多相关视频
07:35Double Labeling Immunofluorescence using Antibodies from the Same Species to Study Host-Pathogen Interactions
Published on: July 10, 2021
6.2K
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
2.4K
相关概念视频
01:10Antibody Structure
58.7K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
58.7K
01:31Hybridoma Technology
13.9K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.9K
01:25Antibody Structure and Classes
723
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
723
00:42Cross-reactivity
30.9K
Overview
30.9K
01:26Antigens Involved in Adaptive Immunity
431
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
431
01:22Immunocytochemistry and Immunohistochemistry
10.5K
Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...
These...
10.5K